This Week’s CGT News: Promising Data for In Vivo CAR T - Top-Institutions - MDSpire
Advertisement
This Week’s CGT News: Promising Data for In Vivo CAR T
Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts